Literature DB >> 8652239

Cyclical tumour variations in premenopausal women with early breast cancer.

R A Badwe1, R Bettelheim, R R Millis, W Gregory, M A Richards, I S Fentiman.   

Abstract

The hormonal milieu at the time of tumour excision may have a significant impact on survival in premenopausal patients with breast cancer, with those undergoing surgery between days 3 and 12 of the menstrual cycle having a worse prognosis. To investigate possible mechanisms which might explain this finding, histological features of tumours from 363 patients included in two studies from Guy's Hospital have been reviewed. Axillary nodal involvement occurred in 71/115 (62%) of patients whose primary tumour was excised between days 3 and 12 of the cycle, compared with 116/248 (47%) of patients undergoing surgery at other phases of the cycle (chi 2 = 7.04, P < 0.01). Vascular invasion was observed in 54/115 (47%) of primary tumours removed between days 3 and 12 and 82/248 (33%) of tumours removed at other times (chi 2 = 6.47, P < 0.02). Multivariate analysis of factors influencing survival indicated that both axillary nodal status and phase of the cycle were highly significant independent predictors of prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8652239     DOI: 10.1016/0959-8049(95)00301-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

2.  Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

Authors:  A Balsari; P Casalini; E Tagliabue; M Greco; S Pilotti; R Agresti; R Giovanazzi; L Alasio; C Rumio; N Cascinelli; M I Colnaghi; S Ménard
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor.

Authors:  Shaojin You; Wei Li; Minoru Kobayashi; Yin Xiong; William Hrushesky; Patricia Wood
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jul-Aug       Impact factor: 2.416

4.  Body weight and vascular invasion in post-menopausal women with breast cancer.

Authors:  R A Badwe; I S Fentiman; R R Millis; W M Gregory
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.

Authors:  P Pujol; J P Daurès; J P Brouillet; T Maudelonde; H Rochefort; J Grenier
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

Authors:  L S Cooper; C E Gillett; P Smith; I S Fentiman; D M Barnes
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.